Literature DB >> 32292798

An Integrative Proteomic/Lipidomic Analysis of the Gold Nanoparticle Biocorona in Healthy and Obese Conditions.

Lisa M Kobos1, Saeed Alqatani1,2, Christina R Ferreira3, Uma K Aryal4, Victoria Hedrick4, Tiago J P Sobreira5, Jonathan H Shannahan1.   

Abstract

Introduction: When nanoparticles (NPs) enter a physiological environment, a coating of biomolecules or biocorona (BC) forms on the surface. Formation of the NP-BC is dependent on NP properties, the physiological environment, and time. The BC influences NP properties and biological interactions such as cellular internalization, immune responses, biodistribution, and others, leading to pharmacological and toxicological consequences. To date, examination of the NP-BC has focused primarily on protein components and healthy conditions. Therefore, we evaluated the protein and lipid content of BCs that formed on physicochemically distinct gold nanoparticles (AuNPs) under healthy and obese conditions. A comprehensive understanding of the NP-BC is necessary for the translation of in vitro toxicity assessments to clinical applications. Materials and
Methods: AuNPs with two coatings (poly-N-vinylpyrrolidone [PVP] or citrate) and diameters (20 or 100 nm) were incubated in pooled human serum, and an integrated proteomic/lipidomic approach was used to evaluate BC composition. Macrophages were utilized to evaluate differential immune responses due to variations in the AuNP-BC.
Results: AuNPs form distinct BCs based on physicochemical properties and the surrounding environment, with the obese BC containing more proteins and fewer lipids than the healthy BC. Differential macrophage inflammatory responses were observed based on AuNP properties and BC composition. Discussion and
Conclusion: Overall, these findings demonstrate that AuNP size and coating, as well as physiological environment, influence the protein and lipid composition of the BC, which impacts cellular responses following exposure. These findings demonstrate that incorporation of BCs representing distinct physiological conditions may enhance the translatability of nanosafety in vitro studies. Copyright 2019, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  corona; in vitro; lipids; macrophages; nanotoxicology; obesity

Year:  2019        PMID: 32292798      PMCID: PMC6768227          DOI: 10.1089/aivt.2019.0005

Source DB:  PubMed          Journal:  Appl In Vitro Toxicol        ISSN: 2332-1512


  69 in total

1.  Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.

Authors:  Carl D Walkey; Jonathan B Olsen; Hongbo Guo; Andrew Emili; Warren C W Chan
Journal:  J Am Chem Soc       Date:  2012-01-23       Impact factor: 15.419

2.  Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.

Authors:  Sherleen Xue-Fu Adamson; Zhoumeng Lin; Ran Chen; Lisa Kobos; Jonathan Shannahan
Journal:  Toxicol In Vitro       Date:  2018-05-05       Impact factor: 3.500

3.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Authors:  Jürgen Cox; Matthias Mann
Journal:  Nat Biotechnol       Date:  2008-11-30       Impact factor: 54.908

4.  Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.

Authors:  Houshang Amiri; Lorenzo Bordonali; Alessandro Lascialfari; Sha Wan; Marco P Monopoli; Iseult Lynch; Sophie Laurent; Morteza Mahmoudi
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

5.  What the cell "sees" in bionanoscience.

Authors:  Dorota Walczyk; Francesca Baldelli Bombelli; Marco P Monopoli; Iseult Lynch; Kenneth A Dawson
Journal:  J Am Chem Soc       Date:  2010-04-28       Impact factor: 15.419

Review 6.  Association between serum amyloid A and obesity: a meta-analysis and systematic review.

Authors:  Yulan Zhao; Xuelian He; Xuegui Shi; Chengjin Huang; Jie Liu; Shuli Zhou; Chew-Kiat Heng
Journal:  Inflamm Res       Date:  2010-02-07       Impact factor: 4.575

7.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response.

Authors:  Gabriele Maiorano; Stefania Sabella; Barbara Sorce; Virgilio Brunetti; Maria Ada Malvindi; Roberto Cingolani; Pier Paolo Pompa
Journal:  ACS Nano       Date:  2010-11-17       Impact factor: 15.881

8.  Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice.

Authors:  Sharda P Singh; Maciej Niemczyk; Deepti Saini; Yogesh C Awasthi; Ludwika Zimniak; Piotr Zimniak
Journal:  Biochemistry       Date:  2008-03-01       Impact factor: 3.162

9.  The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.

Authors:  Karen Fjeldborg; Tore Christiansen; Marianne Bennetzen; Holger J Møller; Steen B Pedersen; Bjørn Richelsen
Journal:  Obesity (Silver Spring)       Date:  2013-07-02       Impact factor: 5.002

10.  Silver nanoparticle protein corona composition in cell culture media.

Authors:  Jonathan H Shannahan; Xianyin Lai; Pu Chun Ke; Ramakrishna Podila; Jared M Brown; Frank A Witzmann
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  3 in total

1.  Changes in target ability of nanoparticles due to protein corona composition and disease state.

Authors:  Wenwen Xu; Mingyu Xu; Yumeng Xiao; Lu Yu; Huiru Xie; Xuehua Jiang; Meiwan Chen; Huile Gao; Ling Wang
Journal:  Asian J Pharm Sci       Date:  2022-04-04       Impact factor: 9.273

2.  Modulation of Pulmonary Toxicity in Metabolic Syndrome Due to Variations in Iron Oxide Nanoparticle-Biocorona Composition.

Authors:  Li Xia; Saeed Alqahtani; Christina R Ferreira; Uma K Aryal; Katelyn Biggs; Jonathan H Shannahan
Journal:  Nanomaterials (Basel)       Date:  2022-06-11       Impact factor: 5.719

3.  Exacerbation of Nanoparticle-Induced Acute Pulmonary Inflammation in a Mouse Model of Metabolic Syndrome.

Authors:  Saeed Alqahtani; Lisa M Kobos; Li Xia; Christina Ferreira; Jackeline Franco; Xuqin Du; Jonathan H Shannahan
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.